Apontis Pharma AG (APPH) — Tangible Net Worth Ratio
Apontis Pharma AG (APPH) has a Tangible Net Worth Ratio of 39.7% as of June 2025. This metric is calculated by deducting intangible assets (€19.08 Million) from net assets (€31.62 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital position of Apontis Pharma AG to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Apontis Pharma AG Tangible Net Worth Ratio (2018–2024)
This chart shows how Apontis Pharma AG's Tangible Net Worth Ratio has changed across 7 annual periods from 2018 to 2024. As of June 2025, the ratio stands at 39.7%, reflecting net assets of €31.62 Million with intangible assets of €19.08 Million EUR. See APPH defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Apontis Pharma AG (2018–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Apontis Pharma AG from 2018 to 2024, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see APPH market cap overview.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 43.1% | €31.02 Million | €17.65 Million | €44.37 Million | ▲ +1.0 pp |
| 2023 | 42.0% | €30.26 Million | €17.54 Million | €57.46 Million | ▼ -19.1 pp |
| 2022 | 61.2% | €41.57 Million | €16.15 Million | €59.85 Million | ▼ -2.8 pp |
| 2021 | 63.9% | €40.71 Million | €14.69 Million | €54.13 Million | ▲ +390.6 pp |
| 2020 | -326.7% | €3.46 Million | €14.76 Million | €29.69 Million | ▼ -89.4 pp |
| 2019 | -237.3% | €4.64 Million | €15.65 Million | €30.59 Million | ▼ -121.9 pp |
| 2018 | -115.4% | €7.03 Million | €15.15 Million | €34.84 Million | — |